Given the wealth of preclinical data attesting to the importance of cGAS-STING in the pathogenesis of cardiac disease, it will be interesting to see if any of these medicinal chemistry breakthroughs reach the clinical trial arena for this indication. This evidence concerns the gene STING1 and heart disorder.